Found 5 matching trials
A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma PHASE3 The purpose of this study was to evaluate safety and efficacy of the combin...
Show More Location
California Cancer Associates for Research and Excellence
Learn More & Join Trial
TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC PHASE2 The purpose of this study is to evaluate the efficacy and safety of transar...
Show More Location
Cancer Center Sun Yat-sen University
Learn More & Join Trial
Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations PHASE2 A double-blind, placebo controlled, randomized, phase II study evaluating t...
Show More Location
Massachusetts General Hospital Liver and Kidney TX
Learn More & Join Trial
A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. NA Based on the interaction between radiation therapy and immunotherapy and th...
Show More Location
Zhengjiang Cancer Hospital
Learn More & Join Trial
Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCC PHASE3 The purpose of this study is to evaluate the efficacy and safety of lenvati...
Show More Location
Cancer Center Sun Yat-sen University
Learn More & Join Trial